Document Detail


Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease.
MedLine Citation:
PMID:  17261464     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Coronary flow reserve (CFR) may be reduced both in arterial hypertension and in hypercholesterolemia. The aim of the study was to assess an association between CFR and levels of plasma total cholesterol (TC) in untreated arterial hypertension. METHODS: We studied 54 consecutive, untreated hypertensive outpatients free of coronary heart disease. Twenty of them had normal TC and 34 high TC (>/=200 mg/dL). Standard echocardiograms and transthoracic Doppler interrogation of the distal left anterior descending artery were obtained. Coronary diastolic peak velocities were measured both at rest and after low-dose dipyridamole. The CFR was calculated as dipyridamole/resting velocities ratio. RESULTS: The two groups had similar age, body mass index, heart rate, and diastolic blood pressure (BP). Patients with high TC had higher systolic BP (P < .05), triglycerides (P < .02), LDL-cholesterol, and TC/HDL-cholesterol ratio (both P < .0001) than controls. Left ventricular (LV) mass index, relative wall thickness, and fractional shortening did not differ between the two groups. Coronary diastolic peak velocities were similar at rest but lower after dipyridamole in patients with high TC (P < .02). As a consequence, CFR was reduced (P < .002). In multiple linear regression analyses, adjusting for age, heart rate, systolic BP, smoking, and relative wall thickness, TC (beta = -0.338) or high LDL-cholesterol (beta = -0.301) (both P < .001) were predictors of lower CFR independently of the concomitant effect of potential confounders. CONCLUSIONS: In hypertensive patients free of coronary artery disease, the degree of impairment in coronary vasodilator capacity is independently associated with plasma cholesterol and LDL-cholesterol.
Authors:
Maurizio Galderisi; Giovanni de Simone; Silvana Cicala; Michele Parisi; Arcangelo D'Errico; Pasquale Innelli; Marcello de Divitiis; Sergio Mondillo; Oreste de Divitiis
Related Documents :
8077574 - Relationship of weight loss to cardiovascular risk factors in morbidly obese individuals.
19680594 - Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemod...
3510614 - Risk factors for changes in aorto-iliac arterial compliance in healthy men.
9519724 - Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in m...
1192574 - Glomerular filtration response to elevated ureteral pressure in both the hydropenic and...
10826464 - Do depression symptoms predict early hypertension incidence in young adults in the card...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of hypertension     Volume:  20     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-01-30     Completed Date:  2007-05-07     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  177-83     Citation Subset:  IM    
Affiliation:
Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy. mgalderi@unina.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cholesterol / blood*
Cholesterol, LDL / blood*
Coronary Circulation*
Coronary Disease
Coronary Vessels / physiopathology*
Female
Humans
Hypercholesterolemia / complications,  diagnosis*,  physiopathology
Hypertension / complications,  diagnosis*,  physiopathology
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Cholesterol, LDL; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Congenic substitution mapping for intracellular Ca2+ in spontaneously hypertensive rats.
Next Document:  Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A c...